Your browser doesn't support javascript.
loading
CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma.
Zhang, Liang; Bi, Enguang; Hong, Sungyoul; Qian, Jianfei; Zheng, Chengyun; Wang, Michael; Yi, Qing.
Affiliation
  • Zhang L; Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Bi E; Deparment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
  • Hong S; Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Qian J; Department of Pharmacy, College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Zheng C; Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wang M; Deparment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
  • Yi Q; Department of Hematology, Second Hospital of Shandong University, Jinan, PR China.
Oncotarget ; 6(34): 36032-40, 2015 Nov 03.
Article in En | MEDLINE | ID: mdl-26447613
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / CD4-Positive T-Lymphocytes / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals Language: En Journal: Oncotarget Year: 2015 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / CD4-Positive T-Lymphocytes / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals Language: En Journal: Oncotarget Year: 2015 Document type: Article Affiliation country: